What I am trying to say is to replace stroke with CHF,.. do the same chart and see where we stand,...?

If the results are there with CHF instead of stroke,.. why shouldn't FDA give it a pass,...?

And you can't use the reasoning that they were testing STROKE in primary endpoint, so if CHF does better it DOES NOT COUNT.